PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
批准号:
2070249
负责人:
BRADLEY E BRITIGAN
金额:
$17.11万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-12-01 至 1998-11-30
关键词:
Pseudomonas aeruginosa bacterial pigment cell adhesion copper cytotoxicity elastases free radical oxygen hydrogen peroxide hydroxyl radical interleukin 1 iron lung injury metal complex microorganism culture neutrophil platelet activating factor prostacyclins protein purification respiratory epithelium siderophores superoxides tissue /cell culture transferrin tumor necrosis factor alpha vascular endothelium
中文摘要
铜绿假单胞菌引起急性和慢性肺部感染
和其他部位导致明显的组织损伤。 形成反应性
氧物种,如超氧化物(O2)过氧化氢(H2 O2),和
羟自由基(OH)与组织损伤的关系日益密切
与一系列人类病理学有关。 OH,通过
铁(Fe)催化的O2和H2 O2的反应,是最具反应性的
氧自由基 我们实验室最近的工作表明,
由铜绿假单胞菌主动分泌的三种化合物可以单独或组合使用,
与中性粒细胞(PMN)衍生的O2/H2 O2结合,导致OH产生
以及随后的组织损伤。 这些产自铜绿假单胞菌的产品是:
绿脓菌螯铁蛋白,一种铜绿假单胞菌铁载体(Fe-螯合剂),
雇用获得微环境FE,我们发现这是一个
有效OH催化剂;假弹性蛋白酶,aP.铜绿蛋白酶
我们发现它可以切割人类铁结合蛋白转铁蛋白,
能够催化OH生成的新型Fe螯合物;以及绿脓菌素aP
可以进行细胞介导的有氧氧化还原循环的铜绿产物
这导致O2和H2 O2的产生。 工作目标
提出的是调查潜在的具体目标已经有针对性
为了学习 目的1将评估铁-绿脓菌螯铁蛋白复合物,
铁绿脓菌螯铁蛋白(Fe-衍生的O2和H2 O2通过诱导OH的产生
靠近细胞膜。 目标2将确定氧化剂种类是什么
铁绿脓菌螯铁蛋白与O2/H2 O2相互作用过程中产生的
绿脓菌螯铁蛋白分子的特征有助于促进其
增强O2/H2 O2-细胞损伤,以及铜-绿脓菌螯铁蛋白是否增强
绿脓菌素通过催化OH产生介导的细胞毒性。 目标4将
确定转铁蛋白的假弹性蛋白酶切割是否也增强
O2/H2O介导的肺上皮和内皮细胞损伤
OH催化。 目标5将调查是否产生
氧化剂通过这些铜绿假单胞菌产物改变内皮细胞功能
a通过增加嗜中性粒细胞粘附进一步促进组织损伤
通过调节粘附配体的表达,
或血小板活化因子(PAF)的内皮细胞表面:
减少内皮细胞前列环素的产生:或增加
内皮细胞释放促炎细胞因子如TNF和
dIL-1。 因此,这些研究将探索新的和以前未探索的
铜绿假单胞菌衍生产品可能有助于
通过诱导产生有毒的氧物质而导致肺损伤。 等
这些信息最终可能会导致新的治疗方法的设计,
采取干预措施,降低艾滋病毒/艾滋病感染的发病率和死亡率,
肺和其他器官感染铜绿假单胞菌和相关细菌病原体。
英文摘要
Pseudomonas aeruginosa causes acute and chronic infections of the lung
and other sites resulting in marked tissue damage. Formation of reactive
oxygen species such as superoxide (O2) hydrogen peroxide (H2O2), and
hydroxyl radical (OH) has been increasingly implicated in tissue injury
associated with a wide array of human pathology. OH, generated via the
iron (Fe)-catalyzed reaction of O2 and H2O2, is the most reactive of the
oxygen free radical. Recent work from our laboratory has suggested that
three compounds actively secreted by P. aeruginosa may alone, or in
conjunction with neutrophil (PMN)-derived O2/H2O2, lead to OH generation
and subsequent tissue injury. These P. aeruginosa-derived products are:
pyochelin, a P. aeruginosa siderophore (Fe-chelator) which P. aeruginosa
employs to acquire microenvironmental FE and which we found is an
effective OH catalyst; pseudomonas elastase, aP. aeruginosa protease
which we found cleaves the human Fe-binding protein transferrin to form
new Fe chelates capable of catalyzing OH production; and pyocyanin aP
aeruginosa product which can undergo cell-mediated aerobic redox cycling
which results in the generation of O2 and H2O2. The goal of the work
proposed is to investigate the potential specific aims have been targeted
for study. Aim 1 will assess whether the iron-pyochelin complex,
ferripyochelin (Fe-derived O2 and H2O2 by inducing the generation of OH
near the cell membrane. Aim 2 will determine what oxidant species are
generated during the interaction of Fe-pyochelin with O2/H2O2 what
features of the pyochelin molecule serve to promote its ability to
enhance O2/H2O2-cell injury, and whether a copper-pyochelin enhances
pyocyanin-mediated cytotoxicity by catalyzing OH generation. Aim 4 will
determine if pseudomonas elastase cleavage of transferrin also enhances
O2/H2O mediated injury of pulmonary epithelial and endothelial cells
through OH catalysis. Aim 5 will investigate whether the generation of
oxidants by these P aeruginosa products alters endothelial cell function
a as to further promote tissue injury by: increasing neutrophil adherence
to endothelial cells by modulating the expression of adherence ligands
or platelet activating factor (PAF) on the endothelial cell surface:
decreasing endothelial cell prostacyclin production: or increasing
endothelial cell release of pro-inflammatory cytokines such as TNF an
dIL-1. Thus, these studies will explore novel and previously unexplored
mechanisms whereby P. aeruginosa-derived products could contribute to
lung injury by inducing the production of toxic oxygen species. Such
information could eventually result in the design of new therapeutic
intervention to decrease the morbidity and mortality of infections of the
lung and other organs with P. aeruginosa and related bacterial pathogens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Gallium-Based Therapies for Pulmonary Mycobacterial Infections
-
批准号:9275424
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
Iron Acquisition by Mycobacterium tuberculosis Within Phagocytes
-
批准号:7685175
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
Iron Acquisition by Mycobacterium tuberculosis Within Phagocytes
-
批准号:8601148
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
Iron Acquisition by Mycobacterium tuberculosis Within Phagocytes
-
批准号:8195964
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
Iron Acquisition by Mycobacterium tuberculosis Within Phagocytes
-
批准号:7784541
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
Use of Gallium to Prevent Pseudomonas Biofilm Formation
-
批准号:6944895
-
项目类别:
-
资助金额:$19.68万
-
财政年份:2004
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
Use of Gallium to Prevent Pseudomonas Biofilm Formation
-
批准号:6807809
-
项目类别:
-
资助金额:$17.18万
-
财政年份:2004
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:6124279
-
项目类别:
-
资助金额:$22.49万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:2607819
-
项目类别:
-
资助金额:$19.75万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:2004014
-
项目类别:
-
资助金额:$18.41万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:2070250
-
项目类别:
-
资助金额:$17.17万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:6624631
-
项目类别:
-
资助金额:$24.57万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:2758868
-
项目类别:
-
资助金额:$23.86万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:6475692
-
项目类别:
-
资助金额:$23.86万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:2070251
-
项目类别:
-
资助金额:$17.78万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
PSEUDOMONAS PRODUCTS, OXYGEN RADICALS, AND LUNG INJURY
-
批准号:6328724
-
项目类别:
-
资助金额:$23.16万
-
财政年份:1993
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
MONOCYTE/MACROPHAGE FREE RADICAL BIOLOGY ASSESSED BY EPR
-
批准号:2221414
-
项目类别:
-
资助金额:$9.3万
-
财政年份:1989
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
MONOCYTE/MACROPHAGE FREE RADICAL BIOLOGY ASSESSED BY EPR
-
批准号:3473001
-
项目类别:
-
资助金额:$9.86万
-
财政年份:1989
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
MONOCYTE/MACROPHAGE FREE RADICAL BIOLOGY ASSESSED BY EPR
-
批准号:3472998
-
项目类别:
-
资助金额:$6.7万
-
财政年份:1989
-
负责人:BRADLEY E BRITIGAN
-
依托单位:
MONOCYTE/MACROPHAGE FREE RADICAL BIOLOGY ASSESSED BY EPR
-
批准号:3472999
-
项目类别:
-
资助金额:$7.63万
-
财政年份:1989
-
负责人:BRADLEY E BRITIGAN
-
依托单位: